Common use of DESIGNATION PROCESS Clause in Contracts

DESIGNATION PROCESS. (a) The Designation as Collaboration Receptor(s) (Lilly) or as a Collaboration Receptor (Arena) under Section 4.1 shall be made solely by the Research Team and recommended to the Steering Committee for approval, as reflected in the Steering Committee Minutes. During the term of this Agreement, and except as expressly provided for under Article III, neither Party shall be permitted to challenge such Designation, in contradiction to a Designation that is reflected in the Minutes. (b) In order to be Designated as either a Collaboration Receptor (Lilly) or as a Collaboration Receptor (Arena), a Party must be the first Party to provide ********** **************************************************** of their respective GPCR to the Research Team for evaluation, as provided for below in Section 4.2(d). The Designation of a GPCR as either a Collaboration Receptor (Lilly) or as a Collaboration Receptor (Arena) shall be based solely upon (i) the terms and conditions of this Agreement and (ii) **************************** ******************************************************** provided by a Party under Section 4.2(d). Once a Party provides its **************** ********************************************* to the Research Team for evaluation as provided below in Section 4.2(d), neither Party shall be permitted to provide any additional information to either the Research Team or Steering Committee in an effort to establish ******************** of a GPCR by that Party. (c) Arena shall submit all of its GPCR-EST receptors and GPCR-Full Length receptors to the Research Team for evaluation as provided in this Section 4.2 and Lilly